Loading...

WuXi AppTec Co., Ltd.

WUXIF•PNK
Healthcare
Medical - Diagnostics & Research
$7.34
$0.00(0.00%)

WuXi AppTec Co., Ltd. (WUXIF) Stock Overview

Explore WuXi AppTec Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap20.1B
P/E Ratio13.39
EPS (TTM)$0.54
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Week$7.34
1 Month$7.20
3 Months$7.08
1 Year Target$3.49

WUXIF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of WuXi AppTec Co., Ltd. (WUXIF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $3.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.39 and a market capitalization of 20.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for WUXIFStats details for WUXIF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for WUXIFAnalyst Recommendations details for WUXIF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

CEO

Ge Li

Employees

39,414

Headquarters

288 Fute Zhong Road, Shanghai

Founded

2020

Frequently Asked Questions

;